EMA Poses Three Questions For the Public Ahead Of Valproate Hearing

 
• By Neena Brizmohun
  
Politician
Speakers at the EMA’s public hearing on valproate must address three questions • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet